re: coramsine/spike/egr Hey Spike , which broader market are you talking about , PGL , for instance was valued at a market cap of approx 11.5 m in 2003(dog status in your opinion) , before the end of their phase 1 trials and is now sitting with a market cap of around 200m on results so far and have not even finished phase 2 . Thats almost a 20 bagger . I could live with that .
I think you probably can foresee how Solbecs cancer trial results will look in comparison .
EGR , coramsine is going to be too late for what by 2005 ?
I get the impression that Solbec is being held up to higher standards than the rest of the industry . I know that PGL went to $14 , but that was before the techwreck burst that bubble . They dropped to the 40-50c range during the four years of phase 1 trials . The technology proved itself in the clinicals and has come back to the $5-$6 range . Same board .
Cheers
- Forums
- ASX - By Stock
- coramsine
SBP
solbec pharmaceuticals limited
re: coramsine/spike/egr Hey Spike , which broader market are you...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online